$5 Billion Brain Scam—Who’s Getting Rich?

Assorted vitamins and supplements scattered around an overturned bottle

Multivitamins—yes, the humble daily pill—may actually slow your brain’s aging, while most “brain booster” supplements do little more than empty your wallet.

Story Snapshot

The $5 billion brain supplement market is booming, but most products lack credible proof they work.
Recent large-scale trials show multivitamins might modestly slow memory decline in older adults.
Popular brands like Prevagen and Neuriva face scrutiny for unsupported claims and inconsistent labeling.
Regulatory oversight is weak, leaving consumers to navigate a confusing landscape of hype and hope.

America’s Brain Health Obsession: How Did We Get Here?

Walk into any pharmacy or scroll social media and you’ll find an avalanche of pills, powders, and potions promising sharper focus, a better memory, and even protection from dementia. This movement didn’t spring from nowhere. The concept of nootropics—substances meant to enhance cognitive function—emerged in the 1970s when scientists first tinkered with piracetam. By the early 2000s, the market for brain supplements exploded, fueled by the aging Baby Boomer generation and a rising tide of fear about Alzheimer’s. Major brands like Prevagen and Neuriva blitzed the airwaves with commercials, and by 2019, over a quarter of Americans aged 50 and older reported using some kind of brain supplement. What drove this gold rush? Smart marketing, regulatory loopholes, and a deep-seated anxiety about losing our minds as we age.

Supplement companies seized on these anxieties. The FDA does not require supplements to prove effectiveness before hitting the shelves, so marketers could make bold—if vague—claims about supporting “brain health.” Consumers, meanwhile, leaned heavily on testimonials and advertising. But as the industry boomed, warnings trickled in from scientists and regulators: buyer beware.

Promises vs. Proof: What Science Really Says

For years, the science lagged behind the hype. Then came the COSMOS trial: a massive, multi-center study tracking thousands of older adults. Published between 2021 and 2024, COSMOS delivered a surprising verdict. Daily multivitamin use showed a modest but measurable benefit, slowing cognitive aging by roughly two years compared to placebo. This is not the stuff of miracle cures—think mental sharpness equivalent to someone two years younger—but it’s real, and it’s more than can be claimed for most other brain supplements on the market.

Most other products—Prevagen, Neuriva, and a parade of herbal blends—failed to clear even the lowest scientific bar. Pharmacists and academic experts, from Harvard to Mass General Brigham, lined up to warn that robust, long-term evidence is lacking for almost all these products. Some supplements are outright mislabeled or adulterated, with ingredients that don’t match what’s on the bottle. This is not just a theoretical risk: the FDA has cited multiple companies for misleading consumers, and independent lab tests continue to reveal quality issues across the industry.

The Regulatory Maze and Why It Matters

The U.S. supplement market operates in a regulatory gray zone. Unlike prescription drugs, supplements don’t need to prove safety or efficacy before being sold. The FDA can intervene only after products are on the market and only if they are proven unsafe or fraudulent. This hands-off approach means that consumers essentially become unwitting test subjects in a never-ending experiment—but with their own money and health on the line.

Manufacturers, driven by profit and market share, spend millions on advertising and influencer partnerships, shaping public perception far more than any clinical study. Regulators and scientists play catch-up, forced to react after misleading products are already in medicine cabinets nationwide. Meanwhile, a small but vocal group of academic researchers and consumer advocates call for tighter regulation and better product labeling, but progress is slow and the market keeps growing.

What’s Worth Your Money—And What Isn’t

Despite the chaos, a few bright spots have emerged. The latest evidence suggests that for older adults, taking a daily multivitamin may offer modest protection against memory decline. This is a far cry from the sweeping promises seen on supplement labels, but it’s a start—and it’s supported by data from large, randomized, peer-reviewed trials. For everything else, the verdict is clear: most brain-boosting supplements are a waste of money, with little more than hope and a slick marketing campaign behind them.

Consumers seeking to protect their brains need to rely on facts, not fads. As more rigorous studies emerge and regulatory scrutiny grows, the industry may be forced to clean up its act. Until then, the best advice is to be skeptical, demand evidence, and remember that the smartest pill on the shelf might just be the one you don’t buy.